Scanning of Neurotransmitters in Children
Summary
Anxiety is the most common childhood disorder, and it can have significant long-term outcomes when not successfully treated. One treatment limitation is poor understanding of what causes anxiety. This study uses a MRI scanner to measure a neurotransmitter system known as the noradrenergic system. The noradrenergic system works in the brain to help with attention, learning, sleep and anxiety. This study will compare this system children with a diagnosis of an anxiety disorder to those without a diagnosis of any anxiety disorder (healthy controls).
We will measure this system using MRI three times, spaced out across a year, to understand how this system is changing with time. As well as MRI, we will get measures of stress, cognition and behavior. We will look at how these relate to the noradrenergic system.
Eligibility
Eligible ages: 8 to 12
Accepts healthy participants: Yes
Inclusion criteria:
Healthy cohort:
1) Aged between 8-12 years
Anxiety cohort:
1) Aged between 8-12 years
2) A diagnosis of an anxiety disorder by a health professional
Exclusion criteria:
1) MRI safety contraindications such as implanted medical devices
2) Inability to read or understand English
3) Concussion within the past 3 months
4) A diagnosis of psychosis, autism, or intellectual disability
5) A diagnosis of a neurological disorder (epilepsy, stroke, cerebral palsy, brain tumor, etc.)
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
If you're interested in this study, please contact Marilena DeMayo at marilena.demayo@ucalgary.ca or 403-210-9268
Principal investigator:
Alexander McGirr
Clinical trial:
No
REB-ID:
REB23-0808